Evaluation of statin prescriptions in type 2 diabetes: India Heart Watch-2
| Autor: | Bhupendra Narayan Mahanta, Krishna K. Sharma, Rajeev Gupta, Arthur J Asirvatham, Anuj Maheshwari, Surendra K. Sharma, Raghubir S Khedar, Sunil Gupta, Dinesh C Sharma, Anand S Meenawat, Sailesh Lodha |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Statin medicine.drug_class Endocrinology Diabetes and Metabolism Atorvastatin 030209 endocrinology & metabolism Type 2 diabetes 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Internal medicine Diabetes mellitus medicine Rosuvastatin Asian Indians Medical prescription Risk factor Vascular disease business.industry Clinical Care/Education/Nutrition/Psychosocial Research nutritional and metabolic diseases Health Service Delivery medicine.disease Lipid-Lowering Drugs/Medication Physical therapy business medicine.drug |
| Zdroj: | BMJ Open Diabetes Research & Care |
| ISSN: | 2052-4897 |
| Popis: | Background Contemporary treatment guidelines advise statin use in all patients with diabetes for reducing coronary risk. Use of statins in patients with type 2 diabetes has not been reported from India. Methods We performed a multisite (n=9) registry-based study among internists (n=3), diabetologists (n=3), and endocrinologists (n=3) across India to determine prescriptions of statins in patients with type 2 diabetes. Demographic and clinical details were obtained and prescriptions were audited for various medications with a focus on statins. Details of type of statin and dosage form (low, moderate, and high) were obtained. Patients were divided into categories based on presence of cardiovascular risk into low (no risk factors, n=1506), medium (≥1 risk factor, n=5425), and high (with vascular disease, n=1769). Descriptive statistics are presented. Results Prescription details were available in 8699 (men 5292, women 3407). Statins were prescribed in 55.2% and fibrates in 9.2%. Statin prescription was significantly greater among diabetologists (64.4%) compared with internists (n=53.3%) and endocrinologists (46.8%; p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|